Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Compound-21a

Home DrugsCompound-21a

Compound-21a

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
Applicant: KAMAL AHMEDPriority: 2008
US
2 publications
9(11)-UNSATURATED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE
Applicant: SAGE THERAPEUTICS INCPriority: 2018
EP
DEUTERATED 21 -[4-CYANO-PYRAZOL-1 -YL]-19-NOR-PREGAN-3. ALPHA-OL-20-ONE DERIVATIVES FOR TREATING CNS DISORDERS
Applicant: SAGE THERAPEUTICS INCPriority: 2017
EP
US
3 publications
Method for stereoselective synthesis of bicyclical heterocycles
Applicant: BOEHRINGER INGELHEIM INTPriority: 2009
EP